0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.18%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-87.18%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-87.18%
Total costs reduction while ECL.AX shows 648.45% growth. Joel Greenblatt would examine advantage.
2127.38%
Interest expense growth above 1.5x ECL.AX's 3.38%. Michael Burry would check for over-leverage.
No Data
No Data available this quarter, please select a different quarter.
-87.18%
EBITDA decline while ECL.AX shows 127.51% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-87.18%
Operating income decline while ECL.AX shows 1214.61% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
74.38%
Other expenses growth while ECL.AX reduces costs. John Neff would investigate differences.
-99.73%
Pre-tax income decline while ECL.AX shows 19.68% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-99.73%
Tax expense reduction while ECL.AX shows 19.68% growth. Joel Greenblatt would examine advantage.
-113.75%
Net income decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-271.43%
EPS decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-271.43%
Diluted EPS decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-42.73%
Share count reduction while ECL.AX shows 62.54% change. Joel Greenblatt would examine strategy.
-42.73%
Diluted share reduction while ECL.AX shows 62.54% change. Joel Greenblatt would examine strategy.